Auro Laboratories Limited (BOM:530233)
India · Delayed Price · Currency is INR 277.50
+5.20 (1.91%)
At close: May 29, 2026
Auro Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 307.4 | 193.98 | 536.35 | 528.94 | 508.66 |
Other Revenue | 20.09 | - | - | - | - |
| 327.49 | 193.98 | 536.35 | 528.94 | 508.66 | |
Revenue Growth (YoY) | 68.82% | -63.83% | 1.40% | 3.99% | -6.24% |
Cost of Revenue | 60.61 | 92.82 | 269.49 | 360.69 | 335.46 |
Gross Profit | 266.88 | 101.16 | 266.86 | 168.26 | 173.19 |
Selling, General & Admin | 58.62 | 24.68 | 51.44 | 47.21 | 62.4 |
Other Operating Expenses | 88.11 | 42.46 | 108.72 | 77.12 | 64.54 |
Operating Expenses | 174.83 | 78.09 | 171.09 | 135.07 | 137.12 |
Operating Income | 92.05 | 23.07 | 95.78 | 33.19 | 36.08 |
Interest Expense | -42.53 | -10.01 | -6.69 | -7.3 | -5.49 |
Interest & Investment Income | - | 0.72 | 0.67 | 1.05 | 3.51 |
Currency Exchange Gain (Loss) | - | 5.77 | 14.32 | 8.36 | 6.95 |
Other Non Operating Income (Expenses) | 0 | -0.74 | -0.61 | -0.84 | -2.78 |
EBT Excluding Unusual Items | 49.52 | 18.81 | 103.46 | 34.46 | 38.28 |
Other Unusual Items | -1.44 | - | - | - | - |
Pretax Income | 48.08 | 18.81 | 103.46 | 34.46 | 38.74 |
Income Tax Expense | 12.75 | 0.42 | 25.54 | 10.04 | 10.29 |
Net Income | 35.33 | 18.39 | 77.92 | 24.42 | 28.45 |
Net Income to Common | 35.33 | 18.39 | 77.92 | 24.42 | 28.45 |
Net Income Growth | 92.14% | -76.40% | 219.09% | -14.15% | -60.38% |
Shares Outstanding (Basic) | 6 | 6 | 6 | 6 | 6 |
Shares Outstanding (Diluted) | 6 | 6 | 6 | 6 | 6 |
Shares Change (YoY) | -0.03% | - | - | - | - |
EPS (Basic) | 5.67 | 2.95 | 12.50 | 3.92 | 4.56 |
EPS (Diluted) | 5.67 | 2.95 | 12.50 | 3.92 | 4.56 |
EPS Growth | 92.20% | -76.40% | 219.03% | -14.07% | -60.41% |
Free Cash Flow | -550.26 | -180.54 | -168.33 | -7.93 | -112 |
Free Cash Flow Per Share | -88.31 | -28.97 | -27.01 | -1.27 | -17.97 |
Gross Margin | 81.49% | 52.15% | 49.76% | 31.81% | 34.05% |
Operating Margin | 28.11% | 11.89% | 17.86% | 6.27% | 7.09% |
Profit Margin | 10.79% | 9.48% | 14.53% | 4.62% | 5.59% |
Free Cash Flow Margin | -168.02% | -93.07% | -31.39% | -1.50% | -22.02% |
EBITDA | 120.15 | 34.03 | 106.7 | 43.93 | 46.25 |
EBITDA Margin | 36.69% | 17.54% | 19.89% | 8.30% | 9.09% |
D&A For EBITDA | 28.1 | 10.96 | 10.92 | 10.74 | 10.17 |
EBIT | 92.05 | 23.07 | 95.78 | 33.19 | 36.08 |
EBIT Margin | 28.11% | 11.89% | 17.86% | 6.27% | 7.09% |
Effective Tax Rate | 26.52% | 2.24% | 24.68% | 29.13% | 26.57% |
Revenue as Reported | 327.49 | 200.54 | 551.39 | 538.36 | 519.58 |